Partnership unites Illumina’s leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO PARK, Calif. — Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and […]
Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers. Innovation has the potential to improve preclinical research by reducing reliance on animal testing through New Approach Methodologies (NAMs) such as organoids and predictive modeling, enabling new directions and scale in advanced biomedical studies. Partnership underscores Bio-Techne’s commitment […]
BICO Group AB today announces the appointment of Ewa Linsäter as Chief Financial Officer. She will succeed Jacob Thordenberg, who has decided to leave BICO to pursue his career outside the Group. Ewa Linsäter has 15+ years’ experience of working as a Chief Financial Officer (CFO) whereof the last six years at Elos Medtech. Prior […]
Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Tahoe Therapeutics has selected Parse’s GigaLab to generate data for its upcoming 300M cell project. Tahoe will use its proprietary Mosaic technology to […]
New priority program opens up exclusive opportunities for collaborative research on transformative clinical potential of DNAe’s flagship tests and to gain preview of breakthrough LiDia-SEQ™ platform LONDON and CARLSBAD, Calif. — DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of […]
Mike Hampton, Chief Commercial Officer, Sapio Sciences Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program. The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale […]
Simoa® HD-X Receives MFDS Class I IVD Import Clearance, Enabling the First Clinical Introduction of Simoa® Technology in Korea Seoul, Republic of Korea – Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics brand Lucent Diagnostics, together with Emocog Inc. (Co-CEOs Jun-Young Lee and Yoo-Hun Noh), a digital […]
Lausanne, Switzerland – Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Esteban Czwan as Chief Commercial Officer, effective 5th December 2025. Esteban will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets. “We are all […]
Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial execution EMERYVILLE, Calif. — Ansa Biotechnologies Inc., the trusted partner for DNA synthesis, today announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer. Mr. Hamilton will report directly to CEO Jason T. Gammack and lead the […]
Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined forces to expand analytical capabilities for protein research. The collaboration combines Cytiva’s Biacore surface plasmon resonance (SPR) systems with Fidabio’s in-solution Flow-Induced Dispersion Analysis (FIDA) technology, providing both a complementary and an […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
